Extracorporeal membrane oxygenation in the treatment of poisoned patients

DW De Lange, MA Sikma, J Meulenbelt - Clinical Toxicology, 2013 - Taylor & Francis
Context. Although extracorporeal membrane oxygenation (ECMO) was used in many
patients following its introduction in 1972, most hospitals had abandoned this experimental …

Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients: A case series and systematic literature review

C Robba, A Ortu, F Bilotta, A Lombardo… - Journal of Trauma …, 2017 - journals.lww.com
BACKGROUND Venovenous extracorporeal membrane oxygenation (vv-ECMO) is an
established salvage therapy for severe respiratory failure, and may provide an alternative …

Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study

TB Enger, A Philipp, V Videm, M Lubnow, A Wahba… - Critical Care, 2014 - Springer
Introduction Veno-venous extracorporeal membrane oxygenation (vvECMO) can be a life-
saving therapy in patients with severe acute lung failure refractory to conventional therapy …

Carnosic acid inhibits reactive oxygen species-dependent neutrophil extracellular trap formation and ameliorates acute respiratory distress syndrome

YF Tsai, SC Yang, YH Hsu, CY Chen, PJ Chen, YT Syu… - Life Sciences, 2023 - Elsevier
Aims Infiltration of activated neutrophils into the lungs is a hallmark of acute respiratory
distress syndrome (ARDS). Neutrophilic inflammation, particularly neutrophil extracellular …

[HTML][HTML] Extracorporeal life support in patients with severe trauma: an advanced treatment strategy for refractory clinical settings

M Bonacchi, R Spina, L Torracchi, G Harmelin… - The Journal of Thoracic …, 2013 - Elsevier
OBJECTIVES: Major trauma is a leading cause of death, particularly among young patients.
New strategies in management are needed to improve poor outcomes in cases of severe …

C1P attenuates lipopolysaccharide-induced acute lung injury by preventing NF-κB activation in neutrophils

K Baudiß, R de Paula Vieira, S Cicko… - The Journal of …, 2016 - journals.aai.org
Abstract Recently, ceramide-1-phosphate (C1P) has been shown to modulate acute
inflammatory events. Acute lung injury (Arnalich et al. 2000. Infect. Immun. 68: 1942–1945) …

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

SC Yang, SH Chang, PW Hsieh, YT Huang… - Free Radical Biology …, 2017 - Elsevier
Abstract Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the
discovery of drugs to treat neutrophilic inflammatory diseases. However, development of …

Interhospital transfer of seriously sick ARDS patients using veno-venous extracorporeal membrane oxygenation (ECMO): concept of an ECMO transport team

CT Starck, P Hasenclever, V Falk… - International journal of …, 2013 - journals.lww.com
Background: Extracorporeal membrane oxygenation (ECMO) therapy constitutes the last
option for patients with acute respiratory distress syndrome (ARDS) refractory to …

Performance of multiple risk assessment tools to predict mortality for adult respiratory distress syndrome with extracorporeal membrane oxygenation therapy: an …

L Huang, T Li, L Xu, XM Hu, DW Duan, ZB Li… - Chinese Medical …, 2016 - mednexus.org
Background: There has been no external validation of survival prediction models for severe
adult respiratory distress syndrome (ARDS) with extracorporeal membrane oxygenation …

ECMO support for right main bronchial disruption in multiple trauma patient with brain injury—a case report and literature review

R Zhou, B Liu, K Lin, R Wang, Z Qin, R Liao… - Perfusion, 2015 - journals.sagepub.com
Extracorporeal membrane oxygenation (ECMO) may offer life-saving treatment in severe
pulmonary contusion or acute respiratory distress syndrome when conventional treatments …